ⅢA-N2期非小细胞肺癌术后生存与复发影响因素及术后放疗和辅助化疗潜在意义
回顾性分析290例经根治性手术和辅助化疗的病理ⅢA-N2期非小细胞肺癌患者,中位生存时间31.5个月,5年生存率33.2%。N2阳性淋巴结数目是总生存的独立影响因素,N2阳性淋巴结数目和组织学类型是局部区域复发的独立影响因素。左肺癌局部区域复发常累及对侧纵隔,右肺癌多位于同侧纵隔。
要点
- 临床N2、鳞状细胞癌、N2阳性淋巴结超过3枚及多个N2站阳性是局部区域复发的不良预后因素。
- N2阳性淋巴结数目是ⅢA-N2期患者总生存的独立影响因素(P=0.017)。
- N2阳性淋巴结数目(P=0.009)和组织学类型(P=0.005)是局部区域复发的独立影响因素。
核心结论
- 临床N2、鳞状细胞癌、N2阳性淋巴结超过3枚及多个N2站阳性是局部区域复发的不良预后因素。
- 左肺癌局部区域复发常累及对侧纵隔,右肺癌局部区域复发多位于同侧纵隔。
研究设计与样本
- 回顾性分析2010年1月至2014年12月在本院接受根治性切除和辅助化疗的290例病理诊断ⅢA-N2期非小细胞肺癌患者的临床资料。
主要发现
- 中位生存时间31.5个月,1年、3年和5年生存率分别为88.3%、46.0%和33.2%。
- 中位局部区域控制时间38.5个月,1年、3年和5年局部区域控制率分别为78.6%、55.2%和41.0%。
- 中位无远处转移生存时间26.8个月,1年、3年和5年无远处转移生存率分别为76.4%、45.5%和39.5%。
- 中位无进展生存时间19.1个月,1年、3年和5年无进展生存率分别为64.1%、32.5%和23.8%。
- 单因素分析显示临床N状态、组织学类型、病理T分期、手术方式、N2阳性淋巴结数目和N2阳性淋巴结站数对总生存有显著影响;临床N状态、组织学类型、N2阳性淋巴结数目和N2阳性淋巴结站数对局部区域控制有显著影响。
关键数值与推荐
- 多因素分析显示N2阳性淋巴结数目(P=0.017)是ⅢA-N2期患者总生存的独立影响因素。
- 多因素分析显示N2阳性淋巴结数目(P=0.009)和组织学类型(P=0.005)是局部区域复发的独立影响因素。
- 左肺癌淋巴结失败站点多位于2R、4R、5、6和7站,常累及对侧纵隔。
- 右肺癌淋巴结失败站点多位于2R、4R、7、10R站和手术残端。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the survival, recurrence patterns and risk factors in patients with stage ⅢA-N2 NSCLC treated with curative surgery and adjuvant chemotherapy and to explore the significance of postoperative radiation therapy. Methods: The clinical data of 290 patients with pathologically diagnosed stage ⅢA-N2 NSCLC after curative resection and adjuvant chemotherapy from January 2010 to December 2014 at our department were retrospectively analyzed. The survival and recurrence patterns were observed, and the factors affecting locoregional recurrence were analyzed. Results: The median survival time was 31.5 months. The 1-, 3-and 5-year survival rates were 88.3%, 46.0% and 33.2%, respectively. The median locoregional control time was 38.5 months. The 1-, 3-and 5-year locoregional control rates were 78.6%, 55.2% and 41.0%, respectively. The median distant metastasis-free survival was 26.8 months. The 1-, 3-and 5-year distant metastasis-free survival rates were 76.4%, 45.5% and 39.5%, respectively. The median progression-free survival was 19.1 months. The 1-, 3-and 5-year progression-free survival rates were 64.1%, 32.5% and 23.8%, respectively. Univariate analysis showed that clinical N status, histological type, pathological T stage, operation mode, the number of positive N2 lymph nodes and the number of positive N2 lymph node stations had a significant influence on overall survival; clinical N status, histological type, the number of positive N2 lymph nodes and the number of positive N2 lymph node stations had a significant influence on locoregional control. Multivariate analysis demonstrated that the number of N2 positive lymph nodes (P= 0.017) was an independent factor for overall survival of stage ⅢA-N2 patients; the number of N2 positive lymph nodes (P=0.009) and histological type (P=0.005) were independent factors for locoregional recurrence. For left-sided lung cancer, the lymph node station failure sites were mostly in 2R, 4R, 5, 6 and 7, and the contralateral mediastinum was frequently involved. For right-sided lung cancer, the lymph node station failure sites were mostly in 2R, 4R, 7, 10R and surgical stump. Conclusions: Clinical N2, squamous cell carcinoma, positive N2 nodes of more than 3 and multiple positive N2 stations are poor prognostic factors for locoregional recurrence. Locoregional recurrence of left lung cancer frequently involves the contralateral mediastinum, while that of the right lung cancer usually locates in the ipsilateral mediastinum.
引用
- Han W, Song YZ, He M, et al. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27998447. doi:10.3760/cma.j.issn.0253-3766.2016.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。